Clinical Experience with 5-Aminosalicylate Preparations in Inflammatory Bowel Disease - A Review
The efficacy of 5-ASA tablets is around 65 co 70% in patients with active ulcerative colitis, whereas the efficacy of the rectal preparations approach 100% when the treatment is for active distal disease. When there is more extensive left sided colonic disease, the efficacy of 5-ASA rectal preparati...
Saved in:
Main Author: | C.N. Williams |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
1987-01-01
|
Series: | Canadian Journal of Gastroenterology |
Online Access: | http://dx.doi.org/10.1155/1987/380401 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Therapy of Inflammatory Bowel Disease using 5-Aminosalicylic Acid, 4-Aminosalicylic Acid and Olsalazine Retention Enemas: Review of Clinical Trials
by: M. Campieri, et al.
Published: (1989-01-01) -
Overview of 5-ASA in Therapy of Inflammatory Bowel Disease
by: CN Williams
Published: (1994-01-01) -
Lupus-Like Syndrome Caused by 5-Aminosalicylic Acid in Patients with Inflammatory Bowel Disease
by: Andrew W Kirkpatrick, et al.
Published: (1999-01-01) -
Antineoplastic Effects of 5-Aminosalicylates and Potential Cancer Preventive Role in Inflammatory Bowel Disease
by: Hugh J Freeman
Published: (2004-01-01) -
Special Issues in Nutritional Therapy of Inflammatory Bowel Disease
by: CN Williams
Published: (1993-01-01)